Pilot Study of a Breast Cancer Vaccine Plus Poly-ICLC for Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: poly-ICLC|BIOLOGICAL: 9 Peptides from Her-2/neu, CEA, & CTA|BIOLOGICAL: Peptide-tet
Sponsor: Craig L Slingluff, Jr